Alzheimer’s disease‐associated post‐translational modifications of tau influence tau propagation
Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated...
Saved in:
Published in | Alzheimer's & dementia Vol. 19; no. S13 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.12.2023
|
Online Access | Get full text |
Cover
Loading…
Abstract | Background
In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated post‐translational modifications (PTMs) of tau reduce its propagation since lysines are critical for LRP1‐mediated tau uptake.
Method
A construct was designed to model tau propagation in Chinese hamster ovary (CHO) cells and allow identification of donor and recipient cells by immunocytochemistry and flow cytometry. In addition to the wildtype (WT) tau sequence, constructs were made with pseudophosphorylation and pseudoacetylation mutations corresponding to the phosphorylations and acetylations found on low molecular weight (LMW) and high molecular weight (HMW) tau species in AD brains. Additionally, individual PTM mimic mutations corresponding to PTMs of the LMW tau species were made. The constructs were transfected into CHO cells and tau propagation was assessed by flow cytometry after 48 hours. Statistical analysis was performed by ANOVA with adjustment for multiple comparisons.
Result
Tau propagation using this cell culture model was demonstrated by immunocytochemistry and flow cytometry. Comparison of the WT, LMW‐mimic (8D2Q mutant), and HMW‐mimic (20D3Q mutant) tau propagation constructs revealed that the 8D2Q and 20D3Q mutants displayed reduced tau propagation compared to WT by 23.7% (p = 0.0186) and 26.5% (p = 0.0087), respectively. Comparing the ten single mutant constructs to WT, T181D and T231D showed increased tau propagation by 20.3% (p = 0.0002) and 15.9% (p = 0.0094), respectively. Compared to WT, T217D, K281Q, K353Q, and S404D showed reduced tau propagation by 17.3% (p = 0.0030), 15.3% (p = 0.0123), 23.7% (p <0.0001), and 16.6% (p = 0.0046), respectively.
Conclusion
The mimics of AD‐associated tau PTMs found on LMW and HMW tau reduce tau propagation, consistent with the initial hypothesis. The impact of individual PTM mimics on tau propagation is variable, but notably both pseudoacetylation mimics reduce propagation, possibly due to lower affinity with LRP1. Understanding how AD‐associated tau PTMs impact tau propagation may suggest novel targets to slow the progression of AD pathology. |
---|---|
AbstractList | Background
In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated post‐translational modifications (PTMs) of tau reduce its propagation since lysines are critical for LRP1‐mediated tau uptake.
Method
A construct was designed to model tau propagation in Chinese hamster ovary (CHO) cells and allow identification of donor and recipient cells by immunocytochemistry and flow cytometry. In addition to the wildtype (WT) tau sequence, constructs were made with pseudophosphorylation and pseudoacetylation mutations corresponding to the phosphorylations and acetylations found on low molecular weight (LMW) and high molecular weight (HMW) tau species in AD brains. Additionally, individual PTM mimic mutations corresponding to PTMs of the LMW tau species were made. The constructs were transfected into CHO cells and tau propagation was assessed by flow cytometry after 48 hours. Statistical analysis was performed by ANOVA with adjustment for multiple comparisons.
Result
Tau propagation using this cell culture model was demonstrated by immunocytochemistry and flow cytometry. Comparison of the WT, LMW‐mimic (8D2Q mutant), and HMW‐mimic (20D3Q mutant) tau propagation constructs revealed that the 8D2Q and 20D3Q mutants displayed reduced tau propagation compared to WT by 23.7% (p = 0.0186) and 26.5% (p = 0.0087), respectively. Comparing the ten single mutant constructs to WT, T181D and T231D showed increased tau propagation by 20.3% (p = 0.0002) and 15.9% (p = 0.0094), respectively. Compared to WT, T217D, K281Q, K353Q, and S404D showed reduced tau propagation by 17.3% (p = 0.0030), 15.3% (p = 0.0123), 23.7% (p <0.0001), and 16.6% (p = 0.0046), respectively.
Conclusion
The mimics of AD‐associated tau PTMs found on LMW and HMW tau reduce tau propagation, consistent with the initial hypothesis. The impact of individual PTM mimics on tau propagation is variable, but notably both pseudoacetylation mimics reduce propagation, possibly due to lower affinity with LRP1. Understanding how AD‐associated tau PTMs impact tau propagation may suggest novel targets to slow the progression of AD pathology. Abstract Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the neuron‐to‐neuron propagation of tau, but the factors that influence tau propagation are not fully understood. We hypothesize that AD‐associated post‐translational modifications (PTMs) of tau reduce its propagation since lysines are critical for LRP1‐mediated tau uptake. Method A construct was designed to model tau propagation in Chinese hamster ovary (CHO) cells and allow identification of donor and recipient cells by immunocytochemistry and flow cytometry. In addition to the wildtype (WT) tau sequence, constructs were made with pseudophosphorylation and pseudoacetylation mutations corresponding to the phosphorylations and acetylations found on low molecular weight (LMW) and high molecular weight (HMW) tau species in AD brains. Additionally, individual PTM mimic mutations corresponding to PTMs of the LMW tau species were made. The constructs were transfected into CHO cells and tau propagation was assessed by flow cytometry after 48 hours. Statistical analysis was performed by ANOVA with adjustment for multiple comparisons. Result Tau propagation using this cell culture model was demonstrated by immunocytochemistry and flow cytometry. Comparison of the WT, LMW‐mimic (8D2Q mutant), and HMW‐mimic (20D3Q mutant) tau propagation constructs revealed that the 8D2Q and 20D3Q mutants displayed reduced tau propagation compared to WT by 23.7% (p = 0.0186) and 26.5% (p = 0.0087), respectively. Comparing the ten single mutant constructs to WT, T181D and T231D showed increased tau propagation by 20.3% (p = 0.0002) and 15.9% (p = 0.0094), respectively. Compared to WT, T217D, K281Q, K353Q, and S404D showed reduced tau propagation by 17.3% (p = 0.0030), 15.3% (p = 0.0123), 23.7% (p <0.0001), and 16.6% (p = 0.0046), respectively. Conclusion The mimics of AD‐associated tau PTMs found on LMW and HMW tau reduce tau propagation, consistent with the initial hypothesis. The impact of individual PTM mimics on tau propagation is variable, but notably both pseudoacetylation mimics reduce propagation, possibly due to lower affinity with LRP1. Understanding how AD‐associated tau PTMs impact tau propagation may suggest novel targets to slow the progression of AD pathology. |
Author | Dickson, John R Sobolewski, Robert Fan, Zhanyun Fernandes, Analiese R Hyman, Bradley T. |
Author_xml | – sequence: 1 givenname: John R surname: Dickson fullname: Dickson, John R email: John.Dickson@MGH.HARVARD.EDU organization: Massachusetts General Hospital, Boston, MA – sequence: 2 givenname: Analiese R surname: Fernandes fullname: Fernandes, Analiese R organization: Massachusetts General Hospital, Charlestown, MA – sequence: 3 givenname: Robert surname: Sobolewski fullname: Sobolewski, Robert organization: Massachusetts General Hospital, Boston, MA – sequence: 4 givenname: Zhanyun surname: Fan fullname: Fan, Zhanyun organization: Massachusetts General Hospital, Boston, MA – sequence: 5 givenname: Bradley T. surname: Hyman fullname: Hyman, Bradley T. organization: Massachusetts General Hospital, Boston, MA |
BookMark | eNp9kL9OwzAQhy1UJNrCwhNkRko5O3aTjFXFP6kSCyws0cU5g5EbR3YqRKc-Aiuv1yehtBUj093vp-9u-EZs0PqWGLvkMOEA4hrdegIFcMhP2JArJVIl8nLwt0_hjI1ifAeQUHA1ZGbm1m9klxS2m--YNDYSRtpuvjBGry321CSdj_2u6QO20WFvfYsuWfrGGqv3MSbeJD2uEtsat6JW0z51wXf4uifO2alBF-niOMfs-fbmaX6fLh7vHuazRao5z_KUk1GaBGRlU3KFmJdK8lxgrQUZMCUXzRQpQyNlLqdFUxCWUFMtM2pIijobs6vDXx18jIFM1QW7xPBZcah-DVU7Q9XB0A7mB_jDOvr8h6xmi5fjzQ8Aq3Bj |
ContentType | Journal Article |
Copyright | 2023 the Alzheimer's Association. |
Copyright_xml | – notice: 2023 the Alzheimer's Association. |
DBID | AAYXX CITATION |
DOI | 10.1002/alz.080107 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1552-5279 |
EndPage | n/a |
ExternalDocumentID | 10_1002_alz_080107 ALZ080107 |
Genre | abstract |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1OC 1~. 1~5 24P 33P 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 8FI 8FJ 8P~ AACTN AAEDT AAHHS AAIKJ AAKOC AALRI AANLZ AAOAW AAXLA AAXUO ABBQC ABCQJ ABCUV ABIVO ABJNI ABMAC ABMZM ABUWG ACCFJ ACCZN ACGFS ACGOF ACPOU ACXQS ADBBV ADBTR ADEZE ADHUB ADKYN ADMUD ADPDF ADVLN ADZMN ADZOD AEEZP AEIGN AEKER AENEX AEQDE AEUYR AEVXI AFKRA AFTJW AGHFR AGUBO AGWIK AGYEJ AITUG AIURR AIWBW AJBDE AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMFUW AMRAJ AMYDB ANZVX AZQEC BENPR BFHJK BLXMC C45 CCPQU DCZOG EBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYUFA G-Q GBLVA HMCUK HVGLF HX~ HZ~ IHE J1W K9- LATKE LEEKS M0R M41 MO0 MOBAO N9A NAPCQ O-L O9- OAUVE OVD OVEED OZT P-8 P-9 P2P PC. PGMZT PIMPY PSYQQ Q38 QTD RIG ROL RPM RPZ SDF SDG SEL SES SSZ SUPJJ T5K TEORI UKHRP ~G- AAYXX CITATION |
ID | FETCH-LOGICAL-c1137-1ef5ce2039d915aa7954172abc2ef0f912d6ae3af447468d8ea90beb43ede42b3 |
ISSN | 1552-5260 |
IngestDate | Fri Aug 23 01:22:21 EDT 2024 Sat Aug 24 00:55:33 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S13 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1137-1ef5ce2039d915aa7954172abc2ef0f912d6ae3af447468d8ea90beb43ede42b3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.080107 |
PageCount | 1 |
ParticipantIDs | crossref_primary_10_1002_alz_080107 wiley_primary_10_1002_alz_080107_ALZ080107 |
PublicationCentury | 2000 |
PublicationDate | December 2023 2023-12-00 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: December 2023 |
PublicationDecade | 2020 |
PublicationTitle | Alzheimer's & dementia |
PublicationYear | 2023 |
SSID | ssj0040815 |
Score | 2.4286714 |
Snippet | Background
In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this is the... Abstract Background In Alzheimer’s disease (AD), tau accumulates with a stereotyped progressive involvement of brain regions. The cellular mechanism for this... |
SourceID | crossref wiley |
SourceType | Aggregation Database Publisher |
Title | Alzheimer’s disease‐associated post‐translational modifications of tau influence tau propagation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falz.080107 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELa2y6WXiopW0NIqEj0hZUkcO8RHBIsQasuhUKFeIjsZq1ttN4jNHtgTj9Arr8eTMI4dJ9s_lV6izcQbJfN9Go8n4xlC3qm0UDTiOoyLmIasFDpUXOpQaq0EANOsKerz4WN6csFOL_nlYHDXy1pa1GpULH-7r-R_UEUZ4mp2yT4CWX9TFOBvxBePiDAe_wnjg-nyK0xM_xOXsiDm7RcXn8Qgnf7RsbwyGzxaeW0mqWkbCvxelSZnqMuLq-XCJGrZBibNGZpaND4dkN9-fgYT-TdEKpuI48Tb-6OJ38bf5On4b0ttDNs2RDYrAphDd_lTpaop2mDbWNumgPu_2ritCXffLGb90AVNemkgztpysxK2DQVG0JfZDjPeRIveBO2nr1-sv60mK6fLEfrBrpvuaoltP4r_eZytBvz-i732hKzhw3A-JGtnn8fjo3aaZ-hL8aYYr3sHX_uW7nV3XvF2-qufxn05XyfP3LojOLAkek4GMNsg2oN3f3s3Dxx17m9_dKQJDGlQskKXYIUuQaUDJEjg6dKc9ejyglwcj88PT0LXeCMs4jjZD2PQvAAaJaIUMZcS35-hoytVQUFHWsS0TCUkUjO2z9KszECKSIFiCZTAqEpekuGsmsEmCZTgIhM8EyUOTdJUGH814qaSXhalSm-RnVZB-ZWtr5LbSto0RzXmVo1bZLfR3V-G5B6xV48Z_Jo87Zi5TYb19QLeoJtZq7cO8AdGOn7Q |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alzheimer%E2%80%99s+disease%E2%80%90associated+post%E2%80%90translational+modifications+of+tau+influence+tau+propagation&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Dickson%2C+John+R&rft.au=Fernandes%2C+Analiese+R&rft.au=Sobolewski%2C+Robert&rft.au=Fan%2C+Zhanyun&rft.date=2023-12-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=19&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Falz.080107&rft.externalDBID=10.1002%252Falz.080107&rft.externalDocID=ALZ080107 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon |